- Tous > Medicine Information and Evidence for Policy > Information and Publications
- Tous > Medicine Information and Evidence for Policy > Medicines Policy
- Tous > Medicine Information and Evidence for Policy > Monitoring and Evaluation
- Tous > Medicine Access and Rational Use > Financing
- Tous > Medicine Access and Rational Use > Good Governance for Medicines
- Tous > Medicine Access and Rational Use > Pricing
- Tous > Medicine Access and Rational Use > Rational Use
- Tous > Medicine Access and Rational Use > Selection
- Tous > Medicine Access and Rational Use > Supply Management
- Tous > Quality and Safety: Medicines > Quality Assurance
- Tous > Quality and Safety: Medicines > Regulatory Support
- Tous > Quality and Safety: Medicines > Safety and Efficacy
- Mots-clés > access to pharmaceutical services
- Mots-clés > annual report
- Mots-clés > availability, affordability, and quality of pharmaceutical products
- Mots-clés > Essential Medicines and Health Products
- Mots-clés > global medicines activities
- Mots-clés > key achievements
- Mots-clés > medicines strategy
- Mots-clés > official development assistance (ODA)
- Mots-clés > progress report
- Mots-clés > Strengthening Pharmaceutical Systems (SPS)
(2012; 40 pages)
Systems for Improved Access to Pharmaceuticals and Services. 2013. Strengthening Pharmaceutical Systems Program Annual Report: Project Year 1, October 2011–September 2012. Submitted to the US Agency for International Development by the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program. Arlington, VA: Management Sciences for Health.
This report presents highlights of SIAPS’s accomplishments in its Program Year 1: October 2011–September 2012.
The US Agency for International Development (USAID) awarded the Management Sciences for Health (MSH) a five-year $197.9 million Co-Operative Agreement, Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program, which is a follow-on to the Strengthening Pharmaceutical Systems (SPS) Program. The program works to assure the availability of quality pharmaceutical products and effective pharmaceutical services to achieve desired health outcomes for the period September 2011 and through September 2016.
The program applies a systems-strengthening approach consistent with the Global Health Initiative (GHI) intended to result in improved and sustainable health impact. The SIAPS’ approach emphasizes GHI principles, especially improving metrics, monitoring and evaluation; empowering local governments and organizations and increasing country ownership. Toward this end, the SIAPS framework and result areas reflect the dynamic relationships among five health systems building blocks, with a pharmaceutical product overlay that guides technical content.
The specific SIAPS results areas include:
- Strengthening pharmaceutical sector governance
- Building individual, organizational, and institutional capacity for pharmaceutical supply management and services
- Addressing the information for decision-making challenge in the pharmaceutical sector
- Strengthening financing strategies and mechanisms to improve access to medicines
- Improving pharmaceutical services to achieve desired health outcomes.
Implemented by a team lead by MSH, the SIAPS core partner team includes the Accreditation Council for Pharmacy Education, Harvard Pilgrim Health Care Institute, Harvard School of Public Health, Logistics Management Institute, and the University of Washington’s Department of Global Health. In addition to these core partners, MSH is joined by a select group of organizations who serve as specialized resource partners for SIAPS. They include the African Medical and Research Foundation, Ecumenical Pharmaceutical Network, Results for Development, RTT Group, Village Reach, and William Davidson Institute at the University of Michigan...